Koninklijke Philips N.V.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Roy Jakobs
- Full Time Employees
- 64,317
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Philips Center Amsterdam NH Netherlands 1077 WV
- IPO Date
- Mar 17, 1980
- CIK
- 0000313216
- Website
- philips.ca
- Similar Companies
- Business
- Koninklijke Philips N.V. is a global health technology company headquartered in Amsterdam, Netherlands, founded in 1891. It operates mainly across the diagnosis and treatment, connected care, and personal health segments, offering a broad range of products and services including precision diagnostic imaging systems, image-guided therapy solutions, patient monitoring devices, health informatics, respiratory care, and personal health and home care products. Its core portfolio features advanced diagnostic imaging devices such as CT and ultrasound systems, AI-enabled clinical decision support tools, enterprise health informatics platforms, sleep and respiratory care solutions, and consumer health categories including grooming and oral healthcare devices. Philips serves markets primarily in North America, Western Europe, Greater China, and other growth geographies. Recent developments include the launch of the AI-powered Philips CT 5300 system, integrating advanced hardware and software with artificial intelligence to enhance imaging quality and boost clinical workflow efficiency. This system offers ultra-low dose screening capabilities and improved diagnostic confidence with smart workflow automation. Philips has also introduced two FDA-cleared AI applications for its Lumify point-of-care ultrasound system, enabling smarter, faster frontline care in anesthesia, emergency medicine, and critical care. Strategically, Philips has maintained cost discipline, restructuring its supply chain and reducing overhead while investing selectively in innovation projects. The company reported a reduced M&A spend in 2023 compared to 2022, focusing on operational improvements and cash preservation. Philips’ business model is arranged into global, end-to-end business units—Diagnosis & Treatment, Connected Care, and Personal Health—each managing their operations independently. Notably, the company is investing in improving productivity and operational efficiency with multi-year savings programs and enhanced product pipeline focus. Its recent partnerships include collaborations with healthcare institutions such as Hôpital Fondation Rothschild in Paris and Erasmus University Medical Center. Philips aims to improve 2.5 billion lives annually by 2030, reflecting its strategic commitment to health technology innovation and broad accessibility. Financially, Philips generated approximately $19.5 billion in revenue in 2024, employing around 67,800 people globally. The company continues to navigate challenges such as supply chain disruptions and market demand fluctuations, particularly in China, while driving growth in mature markets and leveraging AI and digital technologies to reinforce its competitive position in healthcare technology. Its leadership in diagnostic imaging, patient monitoring, connected care, and personal health makes it a key player in the global health technology industry.
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down
Koninklijke Philips N.V. (PHG) Q2 2026 Earnings Call Transcript
Philips Shares Fall After Orders Slip
Koninklijke Philips Q2 Earnings Call Highlights
Royal Philips Reports Increase in Sales, Comparable-Sales Growth
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor
Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments
University Health in San Antonio selects Philips enterprise monitoring platform to transform patient monitoring and advance system-wide standardization as patient volume grows
Philips Home Access Expands its Smart Deadbolt Lineup with New Handleset combos for Prime Day
Royal Philips (PHG) is a Top-Ranked Value Stock: Should You Buy?
Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series
AI is boosting accuracy for clinicians, Philips North America CEO says
NYSE Content Update: HUD Sec. Turner Highlights National Homeownership Month
Philips Future Health Index 2026: AI is already saving clinicians time and delivering measurable impact in healthcare
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
Here's Why Royal Philips (PHG) is a Strong Value Stock